• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钌和锇芳族配合物与修饰后的保罗内酯在人类癌细胞中的生物活性。

Biological activity of ruthenium and osmium arene complexes with modified paullones in human cancer cells.

机构信息

University of Vienna, Institute of Inorganic Chemistry, Währinger Straße 42, A-1090 Vienna, Austria.

出版信息

J Inorg Biochem. 2012 Nov;116(5):180-7. doi: 10.1016/j.jinorgbio.2012.06.003. Epub 2012 Jun 13.

DOI:10.1016/j.jinorgbio.2012.06.003
PMID:23037896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3492762/
Abstract

In an attempt to combine the ability of indolobenzazepines (paullones) to inhibit cyclin-dependent kinases (Cdks) and that of platinum-group metal ions to interact with proteins and DNA, ruthenium(II) and osmium(II) arene complexes with paullones were prepared, expecting synergies and an increase of solubility of paullones. Complexes with the general formula [M(II)Cl(η(6)-p-cymene)L]Cl, where M=Ru (1, 3) or Os (2, 4), and L=L(1) (1, 2) or L(2) (3, 4), L(1)=N-(9-bromo-7,12-dihydroindolo[3,2-d][1]-benzazepin-6(5H)-yliden-N'-(2-hydroxybenzylidene)azine and L(2)=N-(9-bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6-yl)-N'-[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl-methylene]azinium chloride (L(2)(*)HCl), were now investigated regarding cytotoxicity and accumulation in cancer cells, impact on the cell cycle, capacity of inhibiting DNA synthesis and inducing apoptosis as well as their ability to inhibit Cdk activity. The MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide) assay yielded IC(50) values in the nanomolar to low micromolar range. In accordance with cytotoxicity data, the BrdU assay showed that 1 is the most and 4 the least effective of these compounds regarding inhibition of DNA synthesis. Effects on the cell cycle are minor, although concentration-dependent inhibition of Cdk2/cyclin E activity was observed in cell-free experiments. Induction of apoptosis is most pronounced for complex 1, accompanied by a low fraction of necrotic cells, as observed by annexin V-fluorescein isothiocyanate/propidium iodide staining and flow cytometric analysis.

摘要

为了结合吲哚并苯并氮杂卓(保罗酮)抑制细胞周期蛋白依赖性激酶(Cdks)的能力和铂族金属离子与蛋白质和 DNA 相互作用的能力,制备了钌(II)和锇(II)芳烃与保罗酮的配合物,期望协同作用并增加保罗酮的溶解度。具有通式[M(II)Cl(η(6)-p-cymene)L]Cl 的配合物,其中 M=Ru(1、3)或 Os(2、4),和 L=L(1)(1、2)或 L(2)(3、4),L(1)=N-(9-溴-7,12-二氢吲哚并[3,2-d][1]-苯并氮杂卓-6(5H)-亚基-N'-(2-羟基亚苄基)嗪和 L(2)=N-(9-溴-7,12-二氢吲哚并[3,2-d][1]苯并氮杂卓-6-基)-N'-[3-羟基-5-(羟甲基)-2-甲基吡啶-4-基-亚甲基]嗪盐酸盐(L(2)(*)HCl),现在对其细胞毒性和在癌细胞中的积累、对细胞周期的影响、抑制 DNA 合成和诱导细胞凋亡的能力以及抑制 Cdk 活性的能力进行了研究。MTT(3-(4,5-二甲基-2-噻唑基)-2,5-二苯基-2H-四唑溴盐)测定法得出的 IC(50)值在纳摩尔至低微摩尔范围内。与细胞毒性数据一致,BrdU 测定法表明,在这些化合物中,1 是抑制 DNA 合成最有效的,而 4 是最无效的。对细胞周期的影响较小,尽管在无细胞实验中观察到对 Cdk2/细胞周期蛋白 E 活性的浓度依赖性抑制。复合物 1 诱导细胞凋亡的作用最为明显,同时伴有较低比例的坏死细胞,如通过 Annexin V-荧光素异硫氰酸酯/碘化丙啶染色和流式细胞术分析观察到的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/50b8416488ca/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/36f92cf99e8b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/6cb2346d96ad/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/c65e7d10da06/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/24956e49e888/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/489ff17993b2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/c84ade9601ad/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/c3950a3d82cd/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/50b8416488ca/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/36f92cf99e8b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/6cb2346d96ad/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/c65e7d10da06/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/24956e49e888/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/489ff17993b2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/c84ade9601ad/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/c3950a3d82cd/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73c4/3492762/50b8416488ca/gr7.jpg

相似文献

1
Biological activity of ruthenium and osmium arene complexes with modified paullones in human cancer cells.钌和锇芳族配合物与修饰后的保罗内酯在人类癌细胞中的生物活性。
J Inorg Biochem. 2012 Nov;116(5):180-7. doi: 10.1016/j.jinorgbio.2012.06.003. Epub 2012 Jun 13.
2
Organometallic indolo[3,2-c]quinolines versus indolo[3,2-d]benzazepines: synthesis, structural and spectroscopic characterization, and biological efficacy.金属有机吲哚并[3,2-c]喹啉与吲哚并[3,2-d]苯并氮杂卓:合成、结构和光谱特性以及生物功效。
J Biol Inorg Chem. 2010 Aug;15(6):903-18. doi: 10.1007/s00775-010-0653-y. Epub 2010 Apr 6.
3
Effect of the piperazine unit and metal-binding site position on the solubility and anti-proliferative activity of ruthenium(II)- and osmium(II)- arene complexes of isomeric indolo[3,2-c]quinoline-piperazine hybrids.哌嗪单元和金属结合位点位置对异构吲哚并[3,2-c]喹啉-哌嗪杂化物的钌(II)和锇(II)芳烃配合物的溶解度和抗增殖活性的影响。
Inorg Chem. 2014 Jul 7;53(13):6934-43. doi: 10.1021/ic500825j. Epub 2014 Jun 13.
4
Antimalarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands.钌(II)和锇(II)芳烃配合物与单齿和双齿氯喹类似物配体的抗疟活性
Dalton Trans. 2015 Nov 28;44(44):19314-29. doi: 10.1039/c5dt02410b. Epub 2015 Oct 22.
5
Is the reactivity of M(II)-arene complexes of 3-hydroxy-2(1H)-pyridones to biomolecules the anticancer activity determining parameter?3-羟基-2(1H)-吡啶酮的 M(II)-芳基配合物与生物分子的反应性是否是抗癌活性的决定因素?
Inorg Chem. 2010 Sep 6;49(17):7953-63. doi: 10.1021/ic1009785.
6
Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy.基于金属的保罗类化合物作为潜在的细胞周期蛋白依赖性激酶抑制剂用于抗肿瘤化疗。
J Med Chem. 2007 Dec 13;50(25):6343-55. doi: 10.1021/jm701042w. Epub 2007 Nov 13.
7
Ruthenium- and osmium-arene-based paullones bearing a TEMPO free-radical unit as potential anticancer drugs.钌和锇芳基保罗酮作为潜在的抗癌药物,带有 TEMPO 自由基单元。
Chem Commun (Camb). 2012 Sep 4;48(68):8559-61. doi: 10.1039/c2cc33786j. Epub 2012 Jul 16.
8
Highly cytotoxic copper(II) complexes with modified paullone ligands.具有修饰后的保罗内酯配体的高细胞毒性铜(II)配合物。
Inorg Chem. 2010 Jan 4;49(1):302-11. doi: 10.1021/ic902042a.
9
Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity.泡林酮类,一系列细胞周期蛋白依赖性激酶抑制剂:合成、CDK1/细胞周期蛋白B抑制作用评估及体外抗肿瘤活性
J Med Chem. 1999 Jul 29;42(15):2909-19. doi: 10.1021/jm9900570.
10
Synthesis, characterization, HSA/DNA interactions and antitumor activity of new [Ru(η-p-cymene)Cl(L)] complexes.新型[Ru(η-p-cymene)Cl(L)]配合物的合成、表征、与人血清白蛋白的相互作用及抗肿瘤活性。
J Inorg Biochem. 2020 Dec;213:111256. doi: 10.1016/j.jinorgbio.2020.111256. Epub 2020 Sep 15.

引用本文的文献

1
A Half-Sandwich Os(II) Glucoconjugated NHC Complex as a Modulator of Amyloid Aggregation.一种半三明治型Os(II)葡萄糖共轭NHC配合物作为淀粉样蛋白聚集的调节剂。
Inorg Chem. 2025 Feb 24;64(7):3335-3345. doi: 10.1021/acs.inorgchem.4c04823. Epub 2025 Feb 13.
2
Mitochondrial Calcium Uniporter (MCU) is Involved in an Ischemic Postconditioning Effect Against Ischemic Reperfusion Brain Injury in Mice.线粒体钙单向转运蛋白(MCU)参与了缺血后处理对小鼠脑缺血再灌注损伤的保护作用。
Cell Mol Neurobiol. 2024 Apr 3;44(1):32. doi: 10.1007/s10571-024-01464-7.
3
Steric hindrance, ligand ejection and associated photocytotoxic properties of ruthenium(II) polypyridyl complexes.

本文引用的文献

1
Development of an experimental protocol for uptake studies of metal compounds in adherent tumor cells.用于贴壁肿瘤细胞中金属化合物摄取研究的实验方案的制定。
J Anal At Spectrom. 2009 Jan;24(1):51-61. doi: 10.1039/B810481F.
2
Organometallic indolo[3,2-c]quinolines versus indolo[3,2-d]benzazepines: synthesis, structural and spectroscopic characterization, and biological efficacy.金属有机吲哚并[3,2-c]喹啉与吲哚并[3,2-d]苯并氮杂卓:合成、结构和光谱特性以及生物功效。
J Biol Inorg Chem. 2010 Aug;15(6):903-18. doi: 10.1007/s00775-010-0653-y. Epub 2010 Apr 6.
3
Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339.
空间位阻、配体逐出及相关顺铂(II)多吡啶配合物的光细胞毒性性质。
J Biol Inorg Chem. 2023 Jun;28(4):403-420. doi: 10.1007/s00775-023-01998-z. Epub 2023 Apr 15.
4
Self-assembled ruthenium and osmium nanosystems display a potent anticancer profile by interfering with metabolic activity.自组装钌和锇纳米系统通过干扰代谢活性展现出强大的抗癌特性。
Inorg Chem Front. 2022 Jun 7;9(11):2594-2607. doi: 10.1039/d2qi00423b. Epub 2022 Apr 12.
5
Ready access to 7,8-dihydroindolo[2,3-][1]benzazepine-6(5)-one scaffold and analogues via early-stage Fischer ring-closure reaction.通过早期费歇尔闭环反应可方便地获得7,8-二氢吲哚并[2,3-][1]苯并氮杂䓬-6(5)-酮骨架及其类似物。
Beilstein J Org Chem. 2022 Jan 26;18:143-151. doi: 10.3762/bjoc.18.15. eCollection 2022.
6
Tridentate 3-Substituted Naphthoquinone Ruthenium Arene Complexes: Synthesis, Characterization, Aqueous Behavior, and Theoretical and Biological Studies.三齿取代萘醌钌芳烃配合物的合成、表征、水相行为及理论和生物学研究。
Inorg Chem. 2021 Jul 5;60(13):9805-9819. doi: 10.1021/acs.inorgchem.1c01083. Epub 2021 Jun 11.
7
Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells.含苯并稠合巯基吡啶的有机钌配合物克服卵巢癌细胞中的铂耐药性。
Cancers (Basel). 2021 May 20;13(10):2493. doi: 10.3390/cancers13102493.
8
Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo.钌(II)三联吡啶配合物的体外和体内抗肿瘤活性对结肠癌细胞。
Molecules. 2020 Oct 14;25(20):4699. doi: 10.3390/molecules25204699.
9
Polynuclear ruthenium organometallic compounds induce DNA damage in human cells identified by the nucleotide excision repair factor XPC.多核钌有机金属化合物通过核苷酸切除修复因子 XPC 诱导人细胞的 DNA 损伤。
Biosci Rep. 2019 Jul 15;39(7). doi: 10.1042/BSR20190378. Print 2019 Jul 31.
10
Novel latonduine derived proligands and their copper(ii) complexes show cytotoxicity in the nanomolar range in human colon adenocarcinoma cells and in vitro cancer selectivity.新型拉顿丁衍生配体及其铜(II)配合物在纳摩尔范围内对人结肠腺癌细胞表现出细胞毒性,并具有体外癌症选择性。
Dalton Trans. 2019 Jul 16;48(28):10464-10478. doi: 10.1039/c9dt01238a.
抗癌钌药物 KP1019 和 KP1339 的细胞内蛋白结合模式。
J Biol Inorg Chem. 2010 Jun;15(5):737-48. doi: 10.1007/s00775-010-0642-1. Epub 2010 Mar 11.
4
Highly cytotoxic copper(II) complexes with modified paullone ligands.具有修饰后的保罗内酯配体的高细胞毒性铜(II)配合物。
Inorg Chem. 2010 Jan 4;49(1):302-11. doi: 10.1021/ic902042a.
5
Synthesis, X-ray diffraction structure, spectroscopic properties and antiproliferative activity of a novel ruthenium complex with constitutional similarity to cisplatin.一种与顺铂结构相似的新型钌配合物的合成、X射线衍射结构、光谱性质及抗增殖活性
Dalton Trans. 2009 May 7(17):3334-9. doi: 10.1039/b822725j. Epub 2009 Mar 12.
6
From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).从实验室到临床——抗癌药物反式-[四氯双(1H-吲唑)钌(III)] 吲哚鎓盐(KP1019或FFC14A)的临床前及早期临床开发
J Inorg Biochem. 2006 May;100(5-6):891-904. doi: 10.1016/j.jinorgbio.2006.02.013. Epub 2006 Feb 28.
7
Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes.有机金属化学、生物学与医学:钌芳烃抗癌配合物
Chem Commun (Camb). 2005 Oct 14(38):4764-76. doi: 10.1039/b508531b. Epub 2005 Aug 26.
8
Intracellular Targets of Paullones. Identification following affinity purification on immobilized inhibitor.
J Biol Chem. 2002 Jul 12;277(28):25493-501. doi: 10.1074/jbc.M202651200. Epub 2002 Apr 18.
9
Non-platinum chemotherapeutic metallopharmaceuticals.非铂类化疗金属药物。
Chem Rev. 1999 Sep 8;99(9):2511-34. doi: 10.1021/cr9804238.
10
Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells.靛玉红衍生物对人肿瘤细胞中细胞周期蛋白依赖性激酶1(CDK1)的抑制作用。
Br J Cancer. 2001 Jan;84(2):283-9. doi: 10.1054/bjoc.2000.1546.